摘要 |
PCT No. PCT/AU96/00289 Sec. 371 Date Jan. 12, 1998 Sec. 102(e) Date Jan. 12, 1998 PCT Filed May 13, 1996 PCT Pub. No. WO96/36628 PCT Pub. Date Nov. 21, 1996Compounds of formula (I), wherein R1 represents OR5, SR5, NR5R6, N(OR5)R6 or N(NR5R6)R6; X represents OH, N3, NR3R4 or NR4CO2R15; Y represents H or NHR2; R2 represents a group SO2R7 or COR7; R3 represents H, C1-6alkyl or C(=NR8)NR9R10; R4 represents H or C1-6alkyl; R5 represents H, C1-20alkyl, C3-8cycloalkyl, C2-20alkenyl, C2-20alkynyl, CHR11COR12 or C1-20alkyl substituted by one or more groups selected from NR13R14, NR13COR14, CO2R13, OR13, C3-8cycloalkyl and optionally substituted aryl; each R6 independently represents H, C1-6alkyl, C3-8cycloalkyl, C2-6alkenyl, C2-20alkynyl, aryl or C1-4alkyl substituted by one or more groups selected from NR13R14, COR13, C3-8cycloalkyl, CN, N3, OR13 and optionally substituted aryl; or R5 and R6 together form a C2-6 hydrocarbon chain which may optionally contain a group NR13 which chain is optionally substituted by 1, 2, 3 or 4 groups selected from oxo and C1-6alkyl groups which groups may optionally be substituted by hydroxy or optionally substituted aryl; R7 represents C1-6alkyl optionally substituted by one or more halogen atoms, C3-8cycloalkyl or optionally substituted aryl; R8, R9 and R10 each independently represent H, C1-6alkyl, amino, hydroxy, cyano or nitro; R11 represents the side chain of a D- or L-amino acid; R12 represents NR13R14, OR13 or R13; each R13 and each R14 independently represents H, C1-6alkyl or optionally substituted arylC1-4alkyl; R15 represents C1-6alkyl; and their pharmaceutically acceptable derivatives are neuraminidase inhibitors useful in the treatment of viral infections. |